MBRX

$2.49+0.01 (+0.40%)

Pre-Market$2.56+0.07 (+3.01%)· Last close May 5

Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO